The global pharmaceutical ointment and topical cream market has witnessed unprecedented growth over the last decade. As the world transitions toward more personalized medicine and advanced skincare, OEM/ODM ointments factories play a pivotal role in the supply chain. From medical-grade antibiotic creams to high-end aesthetic topicals, the demand for precision manufacturing is at an all-time high.
Globally, the topical drug delivery market is valued at billions of dollars, driven by the rising prevalence of skin disorders, the aging population, and a surge in the aesthetic medicine sector. Industrial hubs in North America and Europe are increasingly looking toward Asia—specifically China—for high-tech, cost-effective manufacturing solutions that don't compromise on GMP standards.
Modern factories are no longer just mixing stations; they are AI-integrated facilities that utilize big data to optimize formulation stability and transdermal absorption rates. This technological shift ensures that products like PCL (Polycaprolactone) serums and HA (Hyaluronic Acid) fillers meet the most stringent international regulations.
The future lies in combining traditional pharmaceutical bases with bio-active peptides and polymers for faster healing.
Global procurement is shifting toward sustainable, recyclable tubes and airless pump systems.
OEM factories are adopting AI to simulate long-term stability tests, reducing R&D time by 40%.
Enterprise buyers from India, South Korea, and Southeast Asia are increasingly seeking partners who offer "full-service" solutions. This includes everything from raw material sourcing (APIs and intermediates) to final packaging and international registration support. Localized application scenarios vary: while the Southeast Asian market demands high-SPF dermatological ointments, the South Korean market focuses heavily on medical aesthetics, such as post-procedure repair creams and liquid face lifts.
Our role as a leading Chinese supplier is to bridge this gap, providing localized formulations that respect regional climate conditions and skin types while maintaining global quality standards.
Hangzhou Jeci Biochem Technology Co., Ltd. is strategically located in Hangzhou, Zhejiang Province—a hub for technological innovation in China. We are more than just a manufacturer; we are your committed partner in the sales of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, nutritional products, and food additives.
Our advantages include:
Our drugs and intermediates are widely utilized in various sectors:
We are capable of assembling and producing larger quantities of intermediates using advanced manufacturing capabilities, including high-efficiency batch processing and bespoke customization. Our facility maximizes efficiency to meet strict customer deadlines without sacrificing quality.
SJ medical
